307 related articles for article (PubMed ID: 16296797)
41. The vagina as a route for systemic drug delivery.
Hussain A; Ahsan F
J Control Release; 2005 Mar; 103(2):301-13. PubMed ID: 15763615
[TBL] [Abstract][Full Text] [Related]
42. Delivery of microbicides to the vagina: difficulties reported with the use of three devices, adherence to use and preferences.
Hardy E; Hebling EM; Sousa MH; Almeida AF; Amaral E
Contraception; 2007 Aug; 76(2):126-31. PubMed ID: 17656182
[TBL] [Abstract][Full Text] [Related]
43. Routes of delivery for progesterone and progestins.
Sitruk-Ware R
Maturitas; 2007 May; 57(1):77-80. PubMed ID: 17368973
[TBL] [Abstract][Full Text] [Related]
44. Factors associated with willingness to use the contraceptive vaginal ring.
Gilliam M; Holmquist S; Berlin A
Contraception; 2007 Jul; 76(1):30-4. PubMed ID: 17586133
[TBL] [Abstract][Full Text] [Related]
45. Distribution of a vaginal gel (Invisible Condom) before, during and after simulated sexual intercourse and its persistence when delivered by two different vaginal applicators: a magnetic resonance imaging study.
Omar RF; Trottier S; Brousseau G; Lamarre A; Alexandre Gagnon ; Bergeron MG
Contraception; 2008 Jun; 77(6):447-55. PubMed ID: 18477496
[TBL] [Abstract][Full Text] [Related]
46. [10 years of research using steroids as controllers of ovulation].
MartÃnez-Manautou J
Gac Med Mex; 1968 Dec; 98(12):1560-75. PubMed ID: 4182066
[No Abstract] [Full Text] [Related]
47. Innovations in contraception: a review.
Zurawin RK; Ayensu-Coker L
Clin Obstet Gynecol; 2007 Jun; 50(2):425-39. PubMed ID: 17513928
[TBL] [Abstract][Full Text] [Related]
48. Comparing patient telephone callback rates for different hormonal birth control delivery systems.
Victor I; Fink RA
Am J Ther; 2006; 13(6):507-12. PubMed ID: 17122531
[TBL] [Abstract][Full Text] [Related]
49. Clinical effectiveness of a new vaginal contraceptive cream; a preliminary report.
BEHNE D; CLARK F; JENNINGS M; PALLAIS V; OLSON H; WOLF L; TYLER ET
West J Surg Obstet Gynecol; 1956 Mar; 64(3):152-7. PubMed ID: 13299945
[No Abstract] [Full Text] [Related]
50. An open-label, multicentre trial to evaluate the vaginal bleeding pattern of the combined contraceptive vaginal ring NuvaRing.
Bruni V; Pontello V; Luisi S; Petraglia F
Eur J Obstet Gynecol Reprod Biol; 2008 Jul; 139(1):65-71. PubMed ID: 18358586
[TBL] [Abstract][Full Text] [Related]
51. Studies on safety aspects of contraceptive Magainin-A in rabbits.
Reddy KV; Aranha C
Indian J Exp Biol; 2000 Dec; 38(12):1217-21. PubMed ID: 11411042
[TBL] [Abstract][Full Text] [Related]
52. Hormonal contraceptive discontinuation patterns according to formulation: investigation of associations in an administrative claims database.
Murphy PA; Brixner D
Contraception; 2008 Apr; 77(4):257-63. PubMed ID: 18342648
[TBL] [Abstract][Full Text] [Related]
53. Pilot study evaluating a progesterone vaginal ring for luteal-phase replacement in donor oocyte recipients.
Stadtmauer L; Harrison DD; Boyd J; Bocca S; Oehninger S
Fertil Steril; 2009 Nov; 92(5):1600-5. PubMed ID: 18990373
[TBL] [Abstract][Full Text] [Related]
54. Contraceptive devices: subcutaneous delivery systems.
Benagiano G; Gabelnick H; Farris M
Expert Rev Med Devices; 2008 Sep; 5(5):623-37. PubMed ID: 18803473
[TBL] [Abstract][Full Text] [Related]
55. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
56. [Clinical aspect of oral contraceptive pills].
Tokuda G
Sanfujinka No Jissai; 1969 Apr; 18(4):327-33. PubMed ID: 5819859
[No Abstract] [Full Text] [Related]
57. A comparison of contraceptive procurement pre- and post-benefit change.
Postlethwaite D; Trussell J; Zoolakis A; Shabear R; Petitti D
Contraception; 2007 Nov; 76(5):360-5. PubMed ID: 17963860
[TBL] [Abstract][Full Text] [Related]
58. Effects of the contraceptive patch, the vaginal ring and an oral contraceptive on APC resistance and SHBG: a cross-over study.
Fleischer K; van Vliet HA; Rosendaal FR; Rosing J; Tchaikovski S; Helmerhorst FM
Thromb Res; 2009; 123(3):429-35. PubMed ID: 18829069
[TBL] [Abstract][Full Text] [Related]
59. [Use of contraceptives in Norway in 2005].
Skjeldestad FE
Tidsskr Nor Laegeforen; 2007 Nov; 127(21):2803-5. PubMed ID: 17987070
[TBL] [Abstract][Full Text] [Related]
60. [Clinical and in vivo experiences with a new contraceptive for topical administration].
Rammstedt D
Med Welt; 1974 Jun; 25(25):1127-8. PubMed ID: 4608658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
